Gervais R - Search Results

1

Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.

Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N, Laurençon V, Henry-Amar M, Bardet S. Andrieux A, et al. Among authors: gervais r. Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77. Q J Nucl Med Mol Imaging. 2006. PMID: 16557206 Free article. Clinical Trial.

2

Unusual intratracheal metastasis of differentiated thyroid cancer accurately depicted by SPECT/CT acquisition after radioiodine ablation.

Aide N, Lehembre E, Gervais R, Bardet S. Aide N, et al. Among authors: gervais r. Thyroid. 2007 Dec;17(12):1305-6. doi: 10.1089/thy.2007.0162. Thyroid. 2007. PMID: 17949266 No abstract available.

3

Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.

Lasnon C, Hicks RJ, Beauregard JM, Milner A, Paciencia M, Guizard AV, Bardet S, Gervais R, Lemoel G, Zalcman G, Aide N. Lasnon C, et al. Among authors: gervais r. Clin Nucl Med. 2012 Oct;37(10):971-6. doi: 10.1097/RLU.0b013e318251e3d1. Clin Nucl Med. 2012. PMID: 22899197

4

Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

Lasnon C, Desmonts C, Quak E, Gervais R, Do P, Dubos-Arvis C, Aide N. Lasnon C, et al. Among authors: gervais r. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):985-96. doi: 10.1007/s00259-013-2391-1. Epub 2013 Apr 6. Eur J Nucl Med Mol Imaging. 2013. PMID: 23564036 Free PMC article. Clinical Trial.

5

Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors.

Barlési F, Balleyguier C, Besse B, Bonodeau F, Brenac F, Corneloup O, Dansin E, Ferretti G, Gaubert JY, Gervais R, Lacombe C, Loundou A, Moro-Sibilot D, Planchard D, Scherpereel A, Menu Y. Barlési F, et al. Among authors: gervais r. Ann Oncol. 2010 Aug;21(8):1682-1686. doi: 10.1093/annonc/mdp590. Epub 2010 Jan 11. Ann Oncol. 2010. PMID: 20064831 Free article.

6

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer.

Gervais R, Hainsworth JD, Blais N, Besse B, Laskin J, Hamm JT, Lipton A, Albain KS, Masters GA, Natale RB, Selaru P, Kim ST, Chao RC, Page RD. Gervais R, et al. Lung Cancer. 2011 Dec;74(3):474-80. doi: 10.1016/j.lungcan.2011.05.004. Epub 2011 Jun 15. Lung Cancer. 2011. PMID: 21680048 Clinical Trial.

7

Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.

Dupont B, Mariotte D, Dugué AE, Clarisse B, Grellard JM, Babin E, Chauffert B, Dakpé S, Moldovan C, Bouhier-Leporrier K, Reimund JM, Di Fiore F, Zanetta S, Mailliez A, Do P, Peytier A, Galais MP, Florescu C, Schott R, Le Mauff B, Gervais R. Dupont B, et al. Among authors: gervais r. Br J Clin Pharmacol. 2017 Mar;83(3):623-631. doi: 10.1111/bcp.13140. Epub 2016 Oct 24. Br J Clin Pharmacol. 2017. PMID: 27662818 Free PMC article.

8

Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study.

Paleiron N, Gervais R, Rousseau-Bussac G, Game LB, Chiappa AM, Lamy R, Guisier F, Le Caer H, Robinet G, Bizieux A, Chouaïd C; GFPC. Paleiron N, et al. Among authors: gervais r. J Cancer Res Ther. 2022 Dec;18(Supplement):S160-S164. doi: 10.4103/jcrt.JCRT_784_20. J Cancer Res Ther. 2022. PMID: 36510958 Free article.

9

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).

Gervais R, Ducolone A, Breton JL, Braun D, Lebeau B, Vaylet F, Debieuvre D, Pujol JL, Tredaniel J, Clouet P, Quoix E. Gervais R, et al. Ann Oncol. 2005 Jan;16(1):90-6. doi: 10.1093/annonc/mdi018. Ann Oncol. 2005. PMID: 15598944 Free article. Clinical Trial.

10

[Oropharyngeal cancer].

Blanchard D, Rame JP, Louis MY, Gery B, Florescu C, de Raucourt D, Gervais R. Blanchard D, et al. Among authors: gervais r. Bull Cancer. 2014 May 1;101(5):429-37. doi: 10.1684/bdc.2014.1957. Bull Cancer. 2014. PMID: 24886893 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page